Amplifon S.p.A. (OTCMKTS:AMFPF – Get Free Report) shares traded down 5.1% on Friday . The company traded as low as $11.97 and last traded at $11.97. 100 shares were traded during trading, a decline of 89% from the average session volume of 930 shares. The stock had previously closed at $12.61.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on the stock. Zacks Research raised shares of Amplifon to a “hold” rating in a report on Tuesday, April 28th. Jefferies Financial Group lowered shares of Amplifon from a “strong-buy” rating to a “hold” rating in a report on Wednesday, March 18th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy”.
View Our Latest Stock Analysis on Amplifon
Amplifon Stock Performance
About Amplifon
Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.
Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.
Featured Stories
- Five stocks we like better than Amplifon
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Receive News & Ratings for Amplifon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amplifon and related companies with MarketBeat.com's FREE daily email newsletter.
